Skip to content
Our Company
Pipeline
Science
Investors
Careers
Contact
Barzolvolimab Treatment Improves Urticaria Activity in Patients with Chronic Spontaneous Urticaria Regardless of Baseline IgE Levels
September 17, 2025
Top